News Focus
News Focus
icon url

FeMike

06/20/25 9:12 PM

#772365 RE: skitahoe #772362

The one time they announced something prematurely it was an intent to file for approval with the UK,



Yep, and the stock ran massively and held value at almost 80% gains for months following that "premature" announcement.

Guess they learned their lesson from that. Don't tell the market what you plan to do, or the stock price might increase. Whoops.

Linda Powerless is a criminal. She is intentionally suppressing the share price. Period, full stop, not debatable. She should be in jail.
icon url

Nemesis18

06/21/25 6:17 AM

#772376 RE: skitahoe #772362

It was certainly the case that as soon as NWBO's MAA application was filed, the NHS, MHRA & FDA's fraud investigation departments, started to pull it apart.
In the UK, the application was immediately pulled out of line, where to this day, a continuous state of RFI, occurred ( with several Agencies either side of the pond, carrying out their own targeted enquiries)

Finally, you are deluded if you still think that the NICE will approve a £2-300 million annual cost on this faux cancer vaccine.

Vulnerable Patients and the NHS Budget will be protected at all costs.
icon url

exwannabe

06/21/25 12:38 PM

#772397 RE: skitahoe #772362

The one time they announced something prematurely it was an intent to file for approval with the UK, and then they had to revise their timing a couple times.


Really, the only time? How about:

Feb '24: Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
That morphed into doing more "optimizations" and then reverting to an earlier design and a year later waiting for clean rooms to be built (that had not been started).

April '20 W Bio To Discuss Projected Schedule For Data Lock, Unblinding and Top Line Data From Its Phase 3 Clinical Trial At Annual Shareholder MeetingBETHESDA, Md
Only missed by 2 years

ASCO 2019, Bosch announces 2 Direct trials to start in coming months
These were different from the new Direct trial Bosch hyped as Asco 2017. None ever launched. And before someone makes the usual "they had no money" excuse, the lack of cash was known when NWBO hyped the trials to be started.

And many other examples can be found.